Perspective Therapeutics Inc (CATX)
3.47
+0.47
(+15.67%)
USD |
NYAM |
Nov 22, 16:00
3.49
+0.02
(+0.58%)
After-Hours: 20:00
Perspective Therapeutics Cash from Operations (Quarterly): 3.366M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 3.366M |
June 30, 2024 | -8.902M |
March 31, 2024 | 13.85M |
December 31, 2023 | -9.008M |
September 30, 2023 | -10.11M |
June 30, 2023 | -8.072M |
March 31, 2023 | -9.723M |
September 30, 2022 | -1.763M |
June 30, 2022 | -2.891M |
March 31, 2022 | -1.422M |
December 31, 2021 | -1.313M |
September 30, 2021 | -2.084M |
June 30, 2021 | -1.118M |
March 31, 2021 | -0.621M |
December 31, 2020 | -0.76M |
September 30, 2020 | -0.338M |
June 30, 2020 | -0.848M |
March 31, 2020 | -0.862M |
December 31, 2019 | -1.278M |
September 30, 2019 | -0.653M |
June 30, 2019 | -0.985M |
March 31, 2019 | -1.338M |
December 31, 2018 | -1.114M |
September 30, 2018 | -1.612M |
June 30, 2018 | -1.448M |
Date | Value |
---|---|
March 31, 2018 | -1.08M |
December 31, 2017 | -1.523M |
September 30, 2017 | -1.661M |
June 30, 2017 | -1.213M |
March 31, 2017 | -1.485M |
December 31, 2016 | -1.661M |
September 30, 2016 | -1.353M |
June 30, 2016 | -1.208M |
March 31, 2016 | -0.756M |
December 31, 2015 | -0.811M |
September 30, 2015 | -1.109M |
June 30, 2015 | -0.6295M |
March 31, 2015 | -1.135M |
December 31, 2014 | -0.6144M |
September 30, 2014 | -1.143M |
June 30, 2014 | -0.989M |
March 31, 2014 | -0.5012M |
December 31, 2013 | -0.846M |
September 30, 2013 | -0.892M |
June 30, 2013 | -0.7863M |
March 31, 2013 | -0.757M |
December 31, 2012 | -0.5744M |
September 30, 2012 | -0.9386M |
June 30, 2012 | -0.6236M |
March 31, 2012 | -0.8101M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-10.11M
Minimum
Sep 2023
13.85M
Maximum
Mar 2024
-2.310M
Average
-1.313M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
Plus Therapeutics Inc | -3.68M |
Retractable Technologies Inc | -5.727M |
InfuSystems Holdings Inc | 9.842M |
Xtant Medical Holdings Inc | -1.718M |
Catheter Precision Inc | -2.768M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -29.74M |
Cash from Financing (Quarterly) | 0.628M |
Free Cash Flow | -40.58M |
Free Cash Flow Per Share (Quarterly) | -0.373 |
Free Cash Flow Yield | -21.77% |